SynAct Pharma AB Tangible Net Worth Ratio
SynAct Pharma AB tangible net worth ratio. SynAct Pharma AB (SYNACT) has a Tangible Net Worth Ratio of 22.0% as of March 2026. This metric is calculated by deducting intangible assets (Skr151.14 Million) from net assets (Skr193.75 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Check asset allocation strategy of SynAct Pharma AB to assess the company's strategic physical and investment asset allocation.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of SynAct Pharma AB (2014–2025)
Tangible net worth ratio of SynAct Pharma AB from 2014 to 2025. This chart shows how SynAct Pharma AB's Tangible Net Worth Ratio has changed across 12 annual periods from 2014 to 2025. As of March 2026, the ratio stands at 22.0%, reflecting net assets of Skr193.75 Million with intangible assets of Skr151.14 Million SEK. See SynAct Pharma AB current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
SynAct Pharma AB Tangible Net Worth Ratio by Year (2014–2025)
SynAct Pharma AB tangible net worth ratio by year from 2014 to 2025. The table below presents the year-by-year Tangible Net Worth Ratio for SynAct Pharma AB from 2014 to 2025, covering 12 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see market value of SynAct Pharma AB.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 13.2% | Skr170.29 Million | Skr147.82 Million | Skr220.52 Million | ▼ -14.6 pp |
| 2024 | 27.8% | Skr214.17 Million | Skr154.59 Million | Skr270.52 Million | ▲ +14.2 pp |
| 2023 | 13.6% | Skr176.19 Million | Skr152.16 Million | Skr228.02 Million | ▼ -86.4 pp |
| 2022 | 100.0% | Skr126.52 Million | Skr0.00 | Skr142.60 Million | ▲ +0.0 pp |
| 2021 | 100.0% | Skr20.87 Million | Skr0.00 | Skr38.37 Million | ▲ +0.0 pp |
| 2020 | 100.0% | Skr15.87 Million | Skr0.00 | Skr21.59 Million | ▲ +9.7 pp |
| 2019 | 90.3% | Skr13.50 Million | Skr1.32 Million | Skr23.81 Million | ▼ -2.3 pp |
| 2018 | 92.5% | Skr10.31 Million | Skr769.34K | Skr14.03 Million | ▲ +0.5 pp |
| 2017 | 92.0% | Skr12.91 Million | Skr1.03 Million | Skr15.23 Million | ▼ -4.3 pp |
| 2016 | 96.3% | Skr27.08 Million | Skr992.95K | Skr30.57 Million | ▲ +87.9 pp |
| 2015 | 8.4% | Skr320.00K | Skr293.00K | Skr377.00K | ▼ -30.7 pp |
| 2014 | 39.1% | Skr642.00K | Skr391.00K | Skr723.00K | — |